资讯

MedPage Today on MSN9 天
Evolut Low Risk TAVR Still Chugging Along, Now Halfway to Trial's Finish Line
CHICAGO -- Transcatheter aortic valve replacement (TAVR) continued to hold its own against surgery for younger patients at ...